Migraine Drugs Underused
New research shows that more migraines could be safely treated with drugs that are known to constrict blood vessels
With only 500 headache specialists in the U.S. to over 38 million sufferers, it is clear more migraine and headache medication is needed. In hopes of providing access to medication for patients who experience aura before migraines, researchers looked at if triptans and Dihydroergotamine (DHE) actually increased the likelihood of a stroke or other cardiovascular side effect. Not only did their study show there was no real risk for patients with aura migraines, but this study could also help nearly 10 million migraine sufferers. “There are not enough medicines out there to appropriately manage migraine headaches,” says senior author Brad Klein, MD, medical director of the Headache Center at Abington Hospital-Jefferson Health. “At a time in history when an unprecedented number of people are getting hooked on narcotic opiates by way of prescribed medications – as is the case with migraine sufferers as well – we owe it to ourselves as physicians to try medications that could work without the risk of addiction,” says Klein. To read more on this study, click here.
2017 AANS/CNS Section on Pediatric Neurological Surgery
Nov. 28-Dec. 1, 2017; Houston
2nd Homburg ICP and Hydrocephalus Workshop
Nov. 28-30, 2017; Germany
22nd Instructional Course and 45th Annual Meeting of the Cervical Spine Research Society
Nov. 29, 2017 - Dec. 2, 2017; Hollywood, Fla.